Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

Clinical trial NCT01617135 · COMPLETED

Trial details

NCT number: NCT01617135
Sponsor: Acorda Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Parkinson's Disease

Start date: 2012-05-01
Primary completion: 2012-11-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.